Clinical Studies

Clinical Studies

Ongoing Clinical Development

  • Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

    Ongoing

    Phase I/II

    More about the study

    The study in the US is being conducted at MD Anderson Cancer Center, TX.

  • Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition (HOVON 172 MF)

    Ongoing

    Phase I/II

    More about the study

    The European study is being conducted within the HOVON research network (Stichting Hemato-Oncologie voor Volwassenen Nederland), with participating clinics in the Netherlands and Germany.